Véronique Dartois Selected Research

aspartate 4-decarboxylase

11/2017

Pyrazinoic Acid Inhibits Mycobacterial Coenzyme A Biosynthesis by Binding to Aspartate Decarboxylase PanD.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Véronique Dartois Research Topics

Disease

61	Tuberculosis (Tuberculoses) 12/2022 - 05/2010
31	Infections 12/2022 - 08/2005
18	Granuloma 11/2021 - 03/2011
5	Lung Diseases (Lung Disease) 01/2022 - 07/2015
5	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2021 - 01/2019
5	Inflammation (Inflammations) 01/2020 - 02/2016
4	Pulmonary Tuberculosis 01/2022 - 02/2016
3	Communicable Diseases (Infectious Diseases) 11/2022 - 01/2020
3	Necrosis 11/2018 - 04/2016
2	Peritonitis 01/2021 - 08/2005
2	Liver Abscess 01/2021 - 01/2020
2	Persistent Infection 01/2020 - 01/2018
2	Meningeal Tuberculosis (Tuberculous Meningitis) 01/2020 - 10/2019
2	Disease Progression 01/2020 - 10/2019
1	Hypoxia (Hypoxemia) 01/2022
1	Starvation 01/2022
1	Brain Neoplasms (Brain Tumor) 12/2021
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 11/2021
1	Metrorrhagia (Spotting) 03/2021
1	Critical Illness (Critically Ill) 03/2021
1	Ototoxicity 01/2021
1	Nontuberculous Mycobacterium Infections 01/2021
1	Breakthrough Infections 01/2021
1	Staphylococcal Infections 01/2021
1	Mycoses (Diseases, Fungus) 01/2020
1	Candidiasis (Moniliasis) 01/2020
1	Immune Reconstitution Inflammatory Syndrome 01/2020
1	Invasive Candidiasis 01/2020
1	Atherosclerosis 01/2018

Drug/Important Bio-Agent (IBA)

51	Pharmaceutical PreparationsIBA 12/2022 - 05/2010
17	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 08/2005
11	Rifampin (Rifampicin)FDA LinkGeneric 12/2022 - 05/2010
9	Pyrazinamide FDA LinkGeneric 12/2019 - 01/2012
7	LipidsIBA 11/2021 - 01/2012
6	Isoniazid (Ftivazide)FDA LinkGeneric 01/2022 - 05/2010
4	EnzymesIBA 10/2019 - 08/2011
4	Moxifloxacin (Avelox)FDA Link 01/2019 - 03/2011
3	FluoroquinolonesIBA 11/2021 - 11/2018
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2012
3	Levofloxacin (Levaquin)FDA Link 01/2019 - 02/2015
3	Proteins (Proteins, Gene)FDA Link 12/2018 - 01/2016
3	pyrazinoic acidIBA 11/2017 - 01/2016
2	CholesterolIBA 12/2022 - 01/2018
2	AminoglycosidesIBA 03/2021 - 01/2021
2	Vancomycin FDA LinkGeneric 03/2021 - 01/2021
2	Streptomycin (Streptomycin Sulfate)FDA Link 03/2021 - 01/2021
2	Amikacin (A.M.K)FDA LinkGeneric 03/2021 - 01/2021
2	Kanamycin FDA Link 03/2021 - 01/2021
2	EchinocandinsIBA 01/2021 - 10/2017
2	Methicillin (Metin)FDA Link 01/2021 - 08/2005
2	RifamycinsIBA 01/2020 - 01/2019
2	Linezolid (Zyvox)FDA Link 01/2020 - 11/2015
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 01/2016
2	Gatifloxacin (Zymar)FDA Link 01/2019 - 08/2017
2	Biological ProductsIBA 01/2018 - 08/2011
2	Ethambutol (Myambutol)FDA LinkGeneric 01/2018 - 01/2017
2	Xanthine OxidaseIBA 10/2017 - 05/2015
2	Allopurinol (Remid)FDA LinkGeneric 10/2017 - 05/2015
2	Antimicrobial PeptidesIBA 01/2016 - 08/2005
1	CarbonIBA 12/2022
1	Cephalosporins (Cephalosporin Antibiotics)IBA 11/2022
1	LactamsIBA 11/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	griselimycinIBA 01/2022
1	MacrolidesIBA 01/2022
1	DepsipeptidesIBA 01/2022
1	Cefotaxime (Kendrick)FDA LinkGeneric 12/2021
1	Topoisomerase II InhibitorsIBA 11/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 11/2021
1	macozinoneIBA 10/2021
1	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 02/2021
1	APX001AIBA 01/2021
1	ginger extractIBA 01/2021
1	quinolineIBA 01/2021
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2020
1	Doxycycline (Periostat)FDA LinkGeneric 01/2020
1	Tetracycline (Achromycin)FDA LinkGeneric 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	TriterpenesIBA 01/2020
1	ibrexafungerpIBA 01/2020
1	Pravastatin (Pravachol)FDA LinkGeneric 01/2020
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2020
1	Rifabutin (Ansamycin)FDA Link 01/2020
1	glucan synthaseIBA 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020
1	Interleukin-1 (Interleukin 1)IBA 01/2020
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2020
1	TBAJ-876IBA 01/2020
1	Oxidoreductases (Dehydrogenase)IBA 10/2019
1	CytochromesIBA 10/2019
1	OPC-67683IBA 10/2019
1	Anthranilate SynthaseIBA 01/2019
1	Protein Kinase CIBA 12/2018
1	Triglycerides (Triacylglycerol)IBA 01/2018
1	Coenzyme A (CoA)IBA 11/2017

Therapy/Procedure

9	Therapeutics 01/2020 - 05/2015
6	Drug Therapy (Chemotherapy) 01/2022 - 05/2010
5	Duration of Therapy 01/2022 - 07/2015
4	Lasers (Laser) 01/2021 - 10/2015
1	Injections 01/2021